(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-20 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 713490
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 90.14 | 88.12 | 90.99 | 87.99 | 1.776 times |
| 19 Thu Dec 2024 | 88.93 | 91.84 | 92.29 | 86.02 | 1.647 times |
| 18 Wed Dec 2024 | 91.78 | 97.05 | 98.41 | 91.16 | 1.347 times |
| 17 Tue Dec 2024 | 96.48 | 94.59 | 96.98 | 94.55 | 0.701 times |
| 16 Mon Dec 2024 | 95.39 | 93.17 | 96.09 | 91.88 | 0.662 times |
| 13 Fri Dec 2024 | 93.19 | 92.72 | 93.77 | 92.00 | 1.113 times |
| 12 Thu Dec 2024 | 92.58 | 94.13 | 94.91 | 92.17 | 1.7 times |
| 11 Wed Dec 2024 | 94.47 | 95.32 | 97.00 | 93.41 | 0.732 times |
| 10 Tue Dec 2024 | 95.39 | 95.23 | 97.44 | 94.47 | 0.611 times |
| 09 Mon Dec 2024 | 94.57 | 96.29 | 97.00 | 94.44 | 0.764 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 91.2, but if it comes above 91.2, then a intra day buy could be more profitable.
If you take a sell trade below 91.2, then use 91.2 as stoploss and 88.4 as target. However if you take a buy trade in stock , then use 91.2 as stoploss and 93.54 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 83.91 |
| Downside Target | 86.02 |
| Upside Target | 91.78 |
| Upside Target | 94.98 |
| Upside Target | 96.50 |
| Upside Target | 97.44 |
| Upside Target | 98.34 |
| Upside Target | 98.41 |
| Upside Target | 103.55 |
| Upside Target | 108.40 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 84.64 |
| Downside Intraday Target | 79.13 |
| Upside Intraday Target | 97.03 |
| Upside Intraday Target | 103.91 |
| Upside Intraday Target | 91.52 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 90.14 | 93.17 | 98.41 | 86.02 | 1.247 times |
| 13 Fri Dec 2024 | 93.19 | 96.29 | 97.44 | 92.00 | 6.797 times |
| 26 Tue Nov 2024 | 94.63 | 93.86 | 95.30 | 91.78 | 0.413 times |
| 26 Tue Nov 2024 | 94.63 | 94.41 | 95.84 | 91.78 | 0.366 times |
| 22 Fri Nov 2024 | 94.15 | 88.43 | 98.34 | 88.05 | 1.244 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 90.14 | 96.29 | 98.41 | 86.02 | 0.638 times |
| 26 Tue Nov 2024 | 94.63 | 87.53 | 103.55 | 87.28 | 0.85 times |
| 31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
| 30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 92.44 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 92.44 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.